摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

phenethyl-succinic acid-anhydride | 100519-02-6

中文名称
——
中文别名
——
英文名称
phenethyl-succinic acid-anhydride
英文别名
Phenaethyl-bernsteinsaeure-anhydrid;3-(2-Phenylethyl)oxolane-2,5-dione
phenethyl-succinic acid-anhydride化学式
CAS
100519-02-6
化学式
C12H12O3
mdl
——
分子量
204.225
InChiKey
KDXLPZHODRUVSS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    phenethyl-succinic acid-anhydride苯胺 生成 2-phenethyl-N-phenyl-succinamic acid
    参考文献:
    名称:
    Ghate; Bhide, Journal of the University of Bombay, Science: Physical Sciences, Mathematics, Biological Sciences and Medicine, 1957, vol. 25/5 A, p. 17,20
    摘要:
    DOI:
  • 作为产物:
    描述:
    styryl-succinic acid 在 磷化氢氢碘酸乙酰氯 作用下, 生成 phenethyl-succinic acid-anhydride
    参考文献:
    名称:
    Thiele; Meisenheimer, Justus Liebigs Annalen der Chemie, 1899, vol. 306, p. 251,254, 263
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Nitroalkanes and Dimethyl Maleate as Source of 3-Alkyl Succinic Anhydrides and (E)-3-Alkylidene Succinic Anhydrides
    作者:Roberto Ballini、Giovanna Bosica、Dennis Fiorini、Paolo Righi
    DOI:10.1055/s-2002-23548
    日期:——
    Nitroalkanes react with dimethyl maleate giving a tandem Michael addition/elimination of nitrous acid. The obtained (E)-2-alkylidene dimethyl succinates are: (i) reduced to the corresponding 2-alkyl dimethyl succinates which after hydrolysis produce 1,4-dicarboxylic acids that are prone to convert into the corresponding 3-alkyl succinic anhydrides or (ii) hydrolysed to (E)-2-alkylidene-succinic acids that
    硝基烷烃与马来酸二甲酯反应产生亚硝酸的串联迈克尔加成/消除。获得的 (E)-2-亚烷基琥珀酸二甲酯是: (i) 还原为相应的琥珀酸 2-烷基二甲酯,水解后产生易于转化为相应的 3-烷基琥珀酸酐的 1,4-二羧酸或 ( ii)水解成(E)-2-亚烷基-琥珀酸,容易环化成(E)-3-亚烷基琥珀酸酐。
  • [EN] ORGANOSILICON COMPOUND, METHOD FOR PRODUCING THEREOF, AND CURABLE SILICONE COMPOSITION CONTAINING THE SAME<br/>[FR] COMPOSÉ ORGANOSILICIUM, PROCÉDÉ POUR LA PRODUCTION DE CELUI-CI, ET COMPOSITION DE SILICONE DURCISSABLE CONTENANT CELUI-CI
    申请人:DOW CORNING TORAY CO LTD
    公开号:WO2011081165A1
    公开(公告)日:2011-07-07
    An objective of the present invention is to provide a curable silicone composition of the present invention exhibiting superior adhesive properties with respect to a poor-adhesive resin such as PPS, even if the composition is cured at a relatively low temperature for a short period. The aforementioned objective of the present invention is achieved by a curable silicone composition comprising: (A) an organopolysiloxane having at least two alkenyl groups in a molecule, (B) an organopolysiloxane having at least two silicon-bonded hydrogen atoms in a molecule, (C) a hydrosilylation-reaction catalyst, and (D) an acid anhydride having an alkoxy group bonding to a silicon atom or an alkoxyalkoxy group bonding to a silicon atom.
    本发明的目标是提供一种可治愈的硅氧烷组合物,即使在相对较低的温度下短时间内治愈,也能表现出对于不良粘附树脂(如PPS)的优越粘附性能。本发明的上述目标通过包括以下成分的可治愈的硅氧烷组合物来实现:(A)分子中至少具有两个烯基基团的有机聚硅氧烷,(B)分子中至少具有两个硅键合氢原子的有机聚硅氧烷,(C)氢硅烷基化反应催化剂,以及(D)酸酐,其具有与硅原子键合的烷氧基或烷氧基烷氧基。
  • Halogen-free epoxy resin composition, prepreg, laminate and printed circuit board containing the same
    申请人:SHENGYI TECHNOLOGY CO., LTD.
    公开号:US10400099B2
    公开(公告)日:2019-09-03
    The present invention relates to a halogen-free epoxy resin composition, a prepreg, a laminate and a printed circuit board containing the same. The halogen-free epoxy resin composition comprises an epoxy resin and a curing agent. Taking the total equivalent amount of the epoxy groups in the epoxy resin as 1, the active groups in the curing agent which react with the epoxy groups have an equivalent amount of 0.5-0.95. By controlling the equivalent ratio of the epoxy groups in the epoxy resin to the active groups in the curing agent to be 0.5-0.95, the present invention ensures the Df value stability of prepregs under different curing temperature conditions while maintaining a low dielectric constant and a low dielectric loss. The prepregs and laminates prepared from the resin composition have comprehensive performances, such as low dielectric constant, low dielectric loss, excellent flame retardancy, heat resistance, cohesiveness, low water absorption and moisture resistance, and are suitable for use in halogen-free multilayer circuit boards.
    本发明涉及一种无卤环氧树脂组合物、一种预浸料、一种层压板和一种含有无卤环氧树脂组合物的印刷电路板。无卤环氧树脂组合物包括环氧树脂和固化剂。环氧树脂中环氧基团的总当量为 1,固化剂中与环氧基团反应的活性基团的当量为 0.5-0.95。通过控制环氧树脂中环氧基团与固化剂中活性基团的当量比为 0.5-0.95,本发明可确保预浸料在不同固化温度条件下的 Df 值稳定性,同时保持低介电常数和低介电损耗。用该树脂组合物制备的预浸料和层压板具有低介电常数、低介电损耗、优异的阻燃性、耐热性、粘合性、低吸水性和防潮性等综合性能,适用于无卤多层电路板。
  • Ramart-Lucas; Papadakis, Annales de Chimie (Cachan, France), 1932, vol. <10> 18, p. 32,48
    作者:Ramart-Lucas、Papadakis
    DOI:——
    日期:——
  • Polymeric pharmaceutical agent for treatment of cancer and method for production of the same
    申请人:Maeda Hiroshi
    公开号:US20090062476A1
    公开(公告)日:2009-03-05
    The present invention provides a polymeric agent which can incorporate a large amount of a drug, accumulate selectively in a tumor site, and has a molecular size of more than that for renal excretion. A metalloporphyrin derivative (such as zinc protoporphyrin) is associated with a styrene-maleic acid copolymer via non-covalent bond to give a SMA micelle complex, allowing provision of a polymeric pharmaceutical agent for treatment of cancer with a large amount of the drug incorporated. The SMA micelle complex can be produced by a method, wherein the metalloporphyrin derivative reacts with the styrene-maleic acid copolymer in the absence of a condensation agent under an alkaline condition, solubilized, adjusted to have a pH of 6-8, and subjected to a procedure for separating a polymer component to recover the micelle complex component for the polymeric pharmaceutical agent.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐